Champlain Investment Partners LLC reduced its position in shares of TriMas Corp (NASDAQ:TRS) by 6.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,113,450 shares of the industrial products company’s stock after selling 142,770 shares during the period. Champlain Investment Partners LLC’s holdings in TriMas were worth $56,535,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Great West Life Assurance Co. Can grew its position in shares of TriMas by 114.4% in the third quarter. Great West Life Assurance Co. Can now owns 6,790 shares of the industrial products company’s stock valued at $183,000 after purchasing an additional 3,623 shares in the last quarter. First Quadrant L P CA purchased a new stake in shares of TriMas in the fourth quarter valued at approximately $195,000. Cigna Investments Inc. New purchased a new stake in shares of TriMas in the fourth quarter valued at approximately $212,000. Thompson Siegel & Walmsley LLC purchased a new stake in shares of TriMas in the third quarter valued at approximately $227,000. Finally, SG Americas Securities LLC acquired a new position in TriMas in the third quarter valued at approximately $228,000. Institutional investors and hedge funds own 98.26% of the company’s stock.
A number of research analysts recently commented on TRS shares. BidaskClub cut TriMas from a “hold” rating to a “sell” rating in a report on Wednesday, November 15th. ValuEngine upgraded TriMas from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Zacks Investment Research upgraded TriMas from a “hold” rating to a “buy” rating and set a $31.00 price objective on the stock in a report on Monday, January 22nd. Finally, Deutsche Bank set a $29.00 price objective on TriMas and gave the company a “hold” rating in a report on Friday, January 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $26.83.
In other TriMas news, CFO Robert J. Zalupski sold 2,816 shares of the company’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $25.94, for a total transaction of $73,047.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.40% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: “Champlain Investment Partners LLC Cuts Holdings in TriMas Corp (TRS)” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/3225043/champlain-investment-partners-llc-cuts-holdings-in-trimas-corp-trs.html.
TriMas Company Profile
TriMas Corporation is a designer, manufacturer and distributor of engineered products for commercial, industrial and consumer markets. The Company operates through four segments: Packaging, Aerospace, Energy and Engineered Components. The Packaging segment is a designer, manufacturer and distributor of engineered closure and dispensing systems for a range of end markets, including steel and plastic industrial, and consumer packaging applications.
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corp (NASDAQ:TRS).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.